Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban plus aspirin in CAD/PAD – real‑world China
CTR20210161Phase 4Completed
- Sponsor
- ---
- Start
- Jan 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban, aspirin in coronary arteriosclerosis, arteriosclerosis obliterans, sponsored by ---. Started Jan 2021; status: completed.
02
Drugs
rivaroxabanaspirin
03
Conditions
coronary arteriosclerosisarteriosclerosis obliterans
Beyond the preview
Go deeper on CTR20210161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210161.